Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Assessment of metabolic phenotypes in patients with non-ischemic dilated cardiomyopathy undergoing cardiac resynchronization therapy.

Journal of cardiovascular translational research - 1 Dec 2010

Obrzut Sebastian, Tiongson Jay, Jamshidi Neema, Phan Huy Minh, Hoh Carl, Birgersdotter-Green Ulrika

Abstract excerpt

Studies of myocardial metabolism have reported that contractile performance at a given myocardial oxygen consumption (MVO2) can be lower when the heart is oxidizing fatty acids rather than glucose or lactate. The objective of this study is to assess the prognostic value of myocardial metabolic phenotypes in identifying non-responders among non-ischemic dilated cardiomyopathy (NIDCM) patients undergoing cardiac...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Fatty Acids, Nonesterified
Share to Lactic Acid

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mitochondria, Heart

Share to Myocardial Contraction

Share to Oxygen Consumption

Share to Pyruvic Acid

Share to Stroke Volume

Share to Ventricular Function, Left

Source

Open in PubMed Open full text

Identifiers

PMID: 20842468
DOI: 10.1007/s12265-010-9223-5
PMCID: PMC2993897

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Assessment of metabolic phenotypes in patients with non-ischemic dilated cardiomyopathy undergoing cardiac resynchronization therapy.PMID 20842468Read ↗

Metabolic task analysis reveals distinct metabotypes in end-stage dilated cardiomyopathySemantic proximity Read ↗

Identifying functional metabolic shifts in heart failure with the integration of omics data and a cardiomyocyte-specific, genome-scale modelSemantic proximity Read ↗

Metabolic Modulation Predicts Heart Failure Tests PerformanceSemantic proximity Read ↗

Left ventricular myocardial molecular profile of human diabetic ischaemic cardiomyopathySemantic proximity Read ↗

Energy Metabolism Dysregulation in Myocardial Infarction: An Integrative Analysis of Ischemic CardiomyopathySemantic proximity Read ↗

Murine metabolic HFpEF is associated with mitochondrial substrate inflexibility and S-nitrosylation remodelingSemantic proximity Read ↗

Quantitative Metabolomics Reveals Heart Failure With Midrange Ejection Fraction as a Distinct Phenotype of Heart Failure.Semantic proximity Read ↗

Integrated left ventricular multi-omics landscape of human cardiometabolic HFpEF.Semantic proximity Read ↗

Ventricle-specific myocardial protein and metabolite characterisation in healthy humans, with differential regulation in end-stage cardiomyopathiesSemantic proximity Read ↗

Metabolic inflexibility across heart failure phenotypes: mechanisms and type-specific therapeutic implications.Semantic proximity Read ↗

Cell-type-resolved Metabolic Flux Inference Reveals Stromal Metabolic Reprogramming Across Human CardiomyopathiesSemantic proximity Read ↗

Metabolic remodeling in hypertrophied and failing myocardium: a review.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.